From Vaccines to Baking Ingredients: The Digest’s 2020 Multi-Slide Guide to Amyris’s Q2

August 11, 2020 |

Earlier this week, Amyris made news with their sugarcane-derived squalene COVID-19 vaccine adjuvant. But how was their Q2 2020 considering all the challenges so far this year?

With a focus on high growth consumer brands, scientific and commercial collaborations, supply chain organization, and more, Amyris had a strong Q2 especially with their record revenue for their consumer brands. How their portfolio has shifted in this new world, strategic priorities, operations updates, 2020 outlook and more.

Prev1 of 21
Use your ← → (arrow) keys to browse

Print Friendly, PDF & Email

Category: 8-Slide Guide

Thank you for visting the Digest.